References
Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Springs MK et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483–6.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593–3.
Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L et al. Human interleukin-17. A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999; 42: 963–70.
Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. I Clin Invest 1999; 103:1345–52.
Lubberts E, Joosten LAB, Chabaud M, Van den Bersselaar, Oppers B, Coenen-de Roo CJJ et al. Local interleukin-4 gene therapy in murine collagen arthritis suppresses IL-17 and osteoprotegerin ligand in the synovium and prevents bone erosion. J Clin Invest 2000; in press.
Lubberts E, Joosten LAB, Van de Loo, Van den Bersselaar, Van den Berg WB. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage. Arthritis Rheum 2000; 43: 1300–06.
Lubberts E, Joosten LAB, Van den Bersselaar L, Helsen MMA, Bakker AC, Van Meurs JBJ et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999; 163: 4546–56.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lubberts, E., Joosten, L.A.B., van de Loo, F.A.J. et al. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res 51, 102–104 (2002). https://doi.org/10.1007/BF02684010
Issue Date:
DOI: https://doi.org/10.1007/BF02684010